X

Stay Connected

Sign Up for Updates

network1.png

PPA strives to improve patient health, advance medical innovation and fuel economic growth.

LEARN MORE
network1.png

The PhRMA Foundation supports the research and career endeavors of scientists in drug discovery and development.

LEARN MORE
network1.png

Access Better Coverage educates consumers about the ABCs of health coverage and access to medicines.

LEARN MORE
network1.png

We Work For Health aims to increase awareness by uniting workers throughout the industry.

LEARN MORE
network1.png

Patent protection should always be considered by an inventor during the initial stages of their invention.

LEARN MORE
logo_white_MyOldMeds-New-1.png

Working to spread awareness and education about the importance of secure drug disposal.

LEARN MORE
LTAC_NEW21.png

Many Americans are struggling to afford their medicines and have important questions about their medicine costs. Let's Talk About Cost addresses these questions.

LEARN MORE
logo_white_LTAM.png

There are a lot of conversations in Washington about how to change Medicare Part D, but they aren't always focused on what seniors care about most: affordability and predictability.

LEARN MORE
 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

EFPIA-PhRMA Principles successfully enable responsible clinical trial data sharing

By Olivia Shopshear  |    November 29, 2017
Stakeholders are gathering in London this week for a workshop entitled Data Anonymization – a Key Enabler for Clinical Data Sharing. The workshop, jointly organized by the European Medicines Agency...   Read More

Guest Post: Film chronicles clinical trials ‘paying it forward’

By Guest Contributor  |    November 28, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Supporting opportunities for enhanced competition in the marketplace

By Andrew Powaleny  |    November 22, 2017
Promoting competition is an important focus for the biopharmaceutical industry. Since 1984, the Hatch-Waxman Act has fostered robust competition through the timely entry of generic medicines into the...   Read More

New report shows better diabetes management saves money and improves patient outcomes

By Carolyn Ha  |    November 21, 2017
A recent IHS Markit report, “The Clinical and Economic Benefits of Better Treatment of Adult Medicaid Beneficiaries with Diabetes,” simulated savings in the Medicaid program as a result of better...   Read More

Medicare Monday: PhRMA’s comments on new direction for CMMI

By Nicole Longo  |    November 20, 2017
Today, PhRMA submitted its comments in response to the Centers for Medicare & Medicaid Services (CMS) request for information on the future of the Center for Medicare and Medicaid Innovation (CMMI)....   Read More

Medicare Monday: Same bad ideas continue to threaten Part D and beneficiary access to medicines

By Nicole Longo  |    November 13, 2017
Perhaps the biggest fact that is often overlooked about Part D is that there is already significant price negotiation in the program. Thanks to Part D’s competitive structure, large purchasers often ...   Read More

Video: What is a results-based contract?

By Katie Koziara  |    November 13, 2017
New medicines are revolutionizing how we fight disease, but too often patients have to fight to access innovative treatments. As part of the solution to this problem, biopharmaceutical companies are...   Read More

Honoring veterans serving in the biopharmaceutical industry

By Andrew Powaleny  |    November 11, 2017
In honor of Veterans Day, we spoke with Rob Caskey, a senior manager in PhRMA’s finance department about his military service, journey to PhRMA and why veterans make great employees for America’s...   Read More

New report and event examine the new era of vaccines

By Andrew Powaleny  |    November 9, 2017
Today, leading minds will come together for an in-depth conversation centered on vaccines – their critical role in warding off disease, the innovative science powering breakthroughs in their research...   Read More

A new era in cancer

By Andrew Powaleny  |    November 1, 2017
The last few years have seen unparalleled progress in cancer care, with breakthrough research driving major advances in diagnosis and treatment. Next week, on Wednesday, November 8, leading minds in...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates

Trending Posts

Most Popular Posts

Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how
we and third parties use pixel tags, and how that use affects you, visit our privacy policy and review
"1. Information Collection."